nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—PTGS2—head and neck cancer	0.435	1	CbGaD
Sulfasalazine—ABCC2—Vinblastine—head and neck cancer	0.0761	0.253	CbGbCtD
Sulfasalazine—ABCG2—Fluorouracil—head and neck cancer	0.0742	0.247	CbGbCtD
Sulfasalazine—ABCC2—Docetaxel—head and neck cancer	0.0627	0.208	CbGbCtD
Sulfasalazine—ABCG2—Docetaxel—head and neck cancer	0.0567	0.188	CbGbCtD
Sulfasalazine—CYP3A5—Docetaxel—head and neck cancer	0.0314	0.104	CbGbCtD
Sulfasalazine—SLC7A11—forelimb zeugopod—head and neck cancer	0.0154	0.174	CbGeAlD
Sulfasalazine—PLA2G1B—exocrine gland—head and neck cancer	0.00424	0.0479	CbGeAlD
Sulfasalazine—SLC7A11—tongue—head and neck cancer	0.00413	0.0467	CbGeAlD
Sulfasalazine—PLA2G1B—mouth—head and neck cancer	0.00317	0.0358	CbGeAlD
Sulfasalazine—SLC7A11—mouth—head and neck cancer	0.00277	0.0314	CbGeAlD
Sulfasalazine—ACAT1—connective tissue—head and neck cancer	0.00277	0.0313	CbGeAlD
Sulfasalazine—TBXAS1—connective tissue—head and neck cancer	0.00232	0.0262	CbGeAlD
Sulfasalazine—CHUK—connective tissue—head and neck cancer	0.00206	0.0234	CbGeAlD
Sulfasalazine—CHUK—epithelium—head and neck cancer	0.00196	0.0222	CbGeAlD
Sulfasalazine—PLA2G1B—connective tissue—head and neck cancer	0.00194	0.022	CbGeAlD
Sulfasalazine—PLA2G1B—epithelium—head and neck cancer	0.00184	0.0208	CbGeAlD
Sulfasalazine—ACAT1—thyroid gland—head and neck cancer	0.00184	0.0208	CbGeAlD
Sulfasalazine—PTGS2—cartilage tissue—head and neck cancer	0.00179	0.0203	CbGeAlD
Sulfasalazine—TBXAS1—lymphoid tissue—head and neck cancer	0.00169	0.0192	CbGeAlD
Sulfasalazine—ACAT1—head—head and neck cancer	0.00163	0.0185	CbGeAlD
Sulfasalazine—TBXAS1—thyroid gland—head and neck cancer	0.00154	0.0174	CbGeAlD
Sulfasalazine—SLC46A1—lymphoid tissue—head and neck cancer	0.00151	0.0171	CbGeAlD
Sulfasalazine—CHUK—lymphoid tissue—head and neck cancer	0.00151	0.0171	CbGeAlD
Sulfasalazine—IKBKB—connective tissue—head and neck cancer	0.0014	0.0159	CbGeAlD
Sulfasalazine—CHUK—thyroid gland—head and neck cancer	0.00137	0.0155	CbGeAlD
Sulfasalazine—SLC46A1—thyroid gland—head and neck cancer	0.00137	0.0155	CbGeAlD
Sulfasalazine—TBXAS1—head—head and neck cancer	0.00136	0.0154	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—head and neck cancer	0.0013	0.541	CrCbGaD
Sulfasalazine—PPARG—neck—head and neck cancer	0.00122	0.0138	CbGeAlD
Sulfasalazine—SLC46A1—head—head and neck cancer	0.00122	0.0138	CbGeAlD
Sulfasalazine—CHUK—head—head and neck cancer	0.00122	0.0138	CbGeAlD
Sulfasalazine—ALOX5—connective tissue—head and neck cancer	0.00116	0.0132	CbGeAlD
Sulfasalazine—PLA2G1B—head—head and neck cancer	0.00114	0.0129	CbGeAlD
Sulfasalazine—ACAT1—lymph node—head and neck cancer	0.00114	0.0129	CbGeAlD
Sulfasalazine—SLC7A11—thyroid gland—head and neck cancer	0.00113	0.0128	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—head and neck cancer	0.00111	0.46	CrCbGaD
Sulfasalazine—IKBKB—lymphoid tissue—head and neck cancer	0.00103	0.0116	CbGeAlD
Sulfasalazine—SLC7A11—head—head and neck cancer	0.001	0.0113	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—head and neck cancer	0.000956	0.0108	CbGeAlD
Sulfasalazine—IKBKB—thyroid gland—head and neck cancer	0.000932	0.0105	CbGeAlD
Sulfasalazine—PPARG—connective tissue—head and neck cancer	0.000873	0.00988	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—head and neck cancer	0.000852	0.00963	CbGeAlD
Sulfasalazine—CHUK—lymph node—head and neck cancer	0.000852	0.00963	CbGeAlD
Sulfasalazine—ALOX5—lymphoid tissue—head and neck cancer	0.000851	0.00962	CbGeAlD
Sulfasalazine—PPARG—epithelium—head and neck cancer	0.000829	0.00938	CbGeAlD
Sulfasalazine—IKBKB—head—head and neck cancer	0.000827	0.00935	CbGeAlD
Sulfasalazine—ALOX5—thyroid gland—head and neck cancer	0.000773	0.00874	CbGeAlD
Sulfasalazine—PTGS2—mouth—head and neck cancer	0.000728	0.00824	CbGeAlD
Sulfasalazine—ALOX5—head—head and neck cancer	0.000685	0.00775	CbGeAlD
Sulfasalazine—PPARG—lymphoid tissue—head and neck cancer	0.000639	0.00722	CbGeAlD
Sulfasalazine—ABCG2—parotid gland—head and neck cancer	0.000636	0.00719	CbGeAlD
Sulfasalazine—ABCG2—saliva-secreting gland—head and neck cancer	0.000609	0.00689	CbGeAlD
Sulfasalazine—PPARG—thyroid gland—head and neck cancer	0.00058	0.00656	CbGeAlD
Sulfasalazine—IKBKB—lymph node—head and neck cancer	0.000579	0.00655	CbGeAlD
Sulfasalazine—PPARG—head—head and neck cancer	0.000515	0.00582	CbGeAlD
Sulfasalazine—ALOX5—lymph node—head and neck cancer	0.00048	0.00543	CbGeAlD
Sulfasalazine—PTGS1—connective tissue—head and neck cancer	0.000467	0.00528	CbGeAlD
Sulfasalazine—PTGS2—connective tissue—head and neck cancer	0.000446	0.00505	CbGeAlD
Sulfasalazine—PTGS1—epithelium—head and neck cancer	0.000443	0.00501	CbGeAlD
Sulfasalazine—PTGS2—epithelium—head and neck cancer	0.000424	0.00479	CbGeAlD
Sulfasalazine—PTGS1—trachea—head and neck cancer	0.000392	0.00443	CbGeAlD
Sulfasalazine—PTGS2—trachea—head and neck cancer	0.000375	0.00424	CbGeAlD
Sulfasalazine—ABCG2—thyroid gland—head and neck cancer	0.000372	0.0042	CbGeAlD
Sulfasalazine—PPARG—lymph node—head and neck cancer	0.00036	0.00407	CbGeAlD
Sulfasalazine—PTGS2—lymphoid tissue—head and neck cancer	0.000326	0.00369	CbGeAlD
Sulfasalazine—ABCC2—lymph node—head and neck cancer	0.000317	0.00358	CbGeAlD
Sulfasalazine—PTGS1—thyroid gland—head and neck cancer	0.00031	0.00351	CbGeAlD
Sulfasalazine—PTGS1—head—head and neck cancer	0.000275	0.00311	CbGeAlD
Sulfasalazine—PTGS2—head—head and neck cancer	0.000263	0.00297	CbGeAlD
Sulfasalazine—ABCG2—lymph node—head and neck cancer	0.000231	0.00261	CbGeAlD
Sulfasalazine—PTGS1—lymph node—head and neck cancer	0.000193	0.00218	CbGeAlD
Sulfasalazine—PTGS2—lymph node—head and neck cancer	0.000184	0.00208	CbGeAlD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	4.43e-05	0.000256	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—head and neck cancer	4.42e-05	0.000255	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—NAT2—head and neck cancer	4.4e-05	0.000254	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	4.4e-05	0.000254	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.39e-05	0.000253	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—MAPK1—head and neck cancer	4.36e-05	0.000252	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—EGFR—head and neck cancer	4.36e-05	0.000252	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—STAT3—head and neck cancer	4.35e-05	0.000251	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—head and neck cancer	4.31e-05	0.000249	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	4.31e-05	0.000249	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CASP8—head and neck cancer	4.3e-05	0.000248	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—head and neck cancer	4.29e-05	0.000248	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—STAT3—head and neck cancer	4.28e-05	0.000247	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.27e-05	0.000247	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PIK3CA—head and neck cancer	4.26e-05	0.000246	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—NAT2—head and neck cancer	4.23e-05	0.000244	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	4.22e-05	0.000244	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—head and neck cancer	4.2e-05	0.000242	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—head and neck cancer	4.2e-05	0.000242	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—DPYD—head and neck cancer	4.17e-05	0.000241	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GRP—head and neck cancer	4.16e-05	0.000241	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MAPK3—head and neck cancer	4.15e-05	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	4.11e-05	0.000238	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MAPK3—head and neck cancer	4.09e-05	0.000236	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CDH1—head and neck cancer	4.08e-05	0.000236	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT6—head and neck cancer	4.04e-05	0.000234	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	4.02e-05	0.000232	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	4.02e-05	0.000232	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTEN—head and neck cancer	4e-05	0.000231	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.96e-05	0.000229	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—YAP1—head and neck cancer	3.96e-05	0.000229	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—MAPK1—head and neck cancer	3.95e-05	0.000228	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—EGFR—head and neck cancer	3.95e-05	0.000228	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—YAP1—head and neck cancer	3.94e-05	0.000228	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CASP8—head and neck cancer	3.9e-05	0.000225	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—MAPK1—head and neck cancer	3.89e-05	0.000225	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—EGFR—head and neck cancer	3.89e-05	0.000225	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—DPYD—head and neck cancer	3.86e-05	0.000223	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	3.85e-05	0.000222	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—head and neck cancer	3.83e-05	0.000221	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—head and neck cancer	3.8e-05	0.00022	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—PIK3CA—head and neck cancer	3.78e-05	0.000218	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.78e-05	0.000218	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.75e-05	0.000217	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.75e-05	0.000217	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—DPYD—head and neck cancer	3.71e-05	0.000214	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CDH1—head and neck cancer	3.7e-05	0.000214	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—BCL2—head and neck cancer	3.69e-05	0.000213	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—YAP1—head and neck cancer	3.66e-05	0.000212	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—YAP1—head and neck cancer	3.58e-05	0.000207	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.57e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.57e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.56e-05	0.000206	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—head and neck cancer	3.56e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.53e-05	0.000204	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—YAP1—head and neck cancer	3.52e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—head and neck cancer	3.5e-05	0.000202	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	3.49e-05	0.000202	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—head and neck cancer	3.48e-05	0.000201	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PIK3CA—head and neck cancer	3.43e-05	0.000198	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PIK3CA—head and neck cancer	3.37e-05	0.000195	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NAT2—head and neck cancer	3.36e-05	0.000194	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—BCL2—head and neck cancer	3.35e-05	0.000193	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTEN—head and neck cancer	3.34e-05	0.000193	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—head and neck cancer	3.33e-05	0.000192	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—STAT3—head and neck cancer	3.3e-05	0.000191	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.29e-05	0.00019	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PIK3CA—head and neck cancer	3.23e-05	0.000187	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—head and neck cancer	3.23e-05	0.000186	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—head and neck cancer	3.17e-05	0.000183	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NAT2—head and neck cancer	3.15e-05	0.000182	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MAPK3—head and neck cancer	3.15e-05	0.000182	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—head and neck cancer	3.12e-05	0.00018	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.09e-05	0.000179	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—head and neck cancer	3.09e-05	0.000178	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL2L1—head and neck cancer	3.06e-05	0.000177	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PTEN—head and neck cancer	3.06e-05	0.000177	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—TYMS—head and neck cancer	3.02e-05	0.000174	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MAPK1—head and neck cancer	3e-05	0.000173	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—EGFR—head and neck cancer	3e-05	0.000173	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.99e-05	0.000173	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSTM1—head and neck cancer	2.98e-05	0.000172	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.97e-05	0.000172	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—DPYD—head and neck cancer	2.94e-05	0.00017	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PTEN—head and neck cancer	2.94e-05	0.00017	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—NOTCH1—head and neck cancer	2.91e-05	0.000168	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GPX1—head and neck cancer	2.86e-05	0.000165	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CYP1A1—head and neck cancer	2.83e-05	0.000163	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PIK3CA—head and neck cancer	2.82e-05	0.000163	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—head and neck cancer	2.8e-05	0.000162	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—YAP1—head and neck cancer	2.79e-05	0.000161	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL2L1—head and neck cancer	2.78e-05	0.000161	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PTEN—head and neck cancer	2.77e-05	0.00016	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—DPYD—head and neck cancer	2.77e-05	0.00016	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—head and neck cancer	2.76e-05	0.000159	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—head and neck cancer	2.72e-05	0.000157	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PTEN—head and neck cancer	2.66e-05	0.000154	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.64e-05	0.000153	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—head and neck cancer	2.64e-05	0.000153	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—YAP1—head and neck cancer	2.63e-05	0.000152	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MAPK3—head and neck cancer	2.61e-05	0.000151	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.59e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NOTCH1—head and neck cancer	2.54e-05	0.000147	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.53e-05	0.000146	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CASP8—head and neck cancer	2.5e-05	0.000145	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—MAPK1—head and neck cancer	2.49e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—EGFR—head and neck cancer	2.48e-05	0.000144	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDH1—head and neck cancer	2.47e-05	0.000143	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—head and neck cancer	2.41e-05	0.000139	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—EGFR—head and neck cancer	2.39e-05	0.000138	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TYMS—head and neck cancer	2.38e-05	0.000137	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTEN—head and neck cancer	2.37e-05	0.000137	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAPK3—head and neck cancer	2.37e-05	0.000137	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PIK3CA—head and neck cancer	2.36e-05	0.000136	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTM1—head and neck cancer	2.35e-05	0.000136	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.32e-05	0.000134	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—head and neck cancer	2.31e-05	0.000133	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.31e-05	0.000133	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CASP8—head and neck cancer	2.27e-05	0.000131	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—MAPK1—head and neck cancer	2.25e-05	0.00013	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—EGFR—head and neck cancer	2.25e-05	0.00013	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GPX1—head and neck cancer	2.25e-05	0.00013	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDH1—head and neck cancer	2.24e-05	0.00013	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	2.23e-05	0.000129	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TYMS—head and neck cancer	2.2e-05	0.000127	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTM1—head and neck cancer	2.17e-05	0.000126	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—EGFR—head and neck cancer	2.16e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PIK3CA—head and neck cancer	2.16e-05	0.000125	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—BCL2—head and neck cancer	2.15e-05	0.000124	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—head and neck cancer	2.12e-05	0.000123	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TYMS—head and neck cancer	2.11e-05	0.000122	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTM1—head and neck cancer	2.09e-05	0.000121	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GPX1—head and neck cancer	2.08e-05	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PIK3CA—head and neck cancer	2.07e-05	0.00012	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CYP1A1—head and neck cancer	2.06e-05	0.000119	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GPX1—head and neck cancer	2e-05	0.000116	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—head and neck cancer	2e-05	0.000115	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.98e-05	0.000114	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PIK3CA—head and neck cancer	1.96e-05	0.000113	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—BCL2—head and neck cancer	1.95e-05	0.000113	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—head and neck cancer	1.93e-05	0.000111	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—head and neck cancer	1.92e-05	0.000111	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL2—head and neck cancer	1.89e-05	0.000109	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—head and neck cancer	1.88e-05	0.000109	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PIK3CA—head and neck cancer	1.88e-05	0.000109	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.83e-05	0.000106	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.83e-05	0.000106	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—head and neck cancer	1.81e-05	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—head and neck cancer	1.78e-05	0.000103	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOTCH1—head and neck cancer	1.78e-05	0.000103	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—head and neck cancer	1.76e-05	0.000102	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—head and neck cancer	1.74e-05	0.0001	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—head and neck cancer	1.72e-05	9.91e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—head and neck cancer	1.69e-05	9.78e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—head and neck cancer	1.68e-05	9.72e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TYMS—head and neck cancer	1.68e-05	9.7e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—head and neck cancer	1.67e-05	9.66e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—head and neck cancer	1.66e-05	9.58e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—head and neck cancer	1.64e-05	9.5e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.63e-05	9.4e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—head and neck cancer	1.61e-05	9.33e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOTCH1—head and neck cancer	1.61e-05	9.32e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAPK3—head and neck cancer	1.61e-05	9.31e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—head and neck cancer	1.6e-05	9.23e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—head and neck cancer	1.59e-05	9.2e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GPX1—head and neck cancer	1.59e-05	9.18e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.58e-05	9.11e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CYP1A1—head and neck cancer	1.57e-05	9.09e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.56e-05	9e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—head and neck cancer	1.53e-05	8.86e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK3—head and neck cancer	1.52e-05	8.79e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOTCH1—head and neck cancer	1.5e-05	8.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.49e-05	8.62e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.48e-05	8.54e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—head and neck cancer	1.47e-05	8.5e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—head and neck cancer	1.47e-05	8.47e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK1—head and neck cancer	1.45e-05	8.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EGFR—head and neck cancer	1.45e-05	8.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—head and neck cancer	1.44e-05	8.34e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK3—head and neck cancer	1.4e-05	8.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK3—head and neck cancer	1.38e-05	7.97e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—head and neck cancer	1.37e-05	7.89e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK1—head and neck cancer	1.34e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EGFR—head and neck cancer	1.34e-05	7.72e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—head and neck cancer	1.32e-05	7.65e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK1—head and neck cancer	1.31e-05	7.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EGFR—head and neck cancer	1.31e-05	7.58e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.29e-05	7.46e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—head and neck cancer	1.26e-05	7.26e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—head and neck cancer	1.23e-05	7.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—head and neck cancer	1.22e-05	7.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—head and neck cancer	1.19e-05	6.89e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—head and neck cancer	1.18e-05	6.81e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—head and neck cancer	1.16e-05	6.72e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—head and neck cancer	1.16e-05	6.7e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—head and neck cancer	1.15e-05	6.67e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—head and neck cancer	1.15e-05	6.65e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—head and neck cancer	1.14e-05	6.58e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—head and neck cancer	1.11e-05	6.41e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—head and neck cancer	1.09e-05	6.28e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—head and neck cancer	1.08e-05	6.25e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—head and neck cancer	1.07e-05	6.2e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—head and neck cancer	1.07e-05	6.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—head and neck cancer	1.05e-05	6.09e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—head and neck cancer	1.04e-05	6.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—head and neck cancer	1.04e-05	6.01e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—head and neck cancer	1.03e-05	5.98e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—head and neck cancer	1.03e-05	5.95e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—head and neck cancer	1.03e-05	5.94e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—head and neck cancer	1.03e-05	5.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK3—head and neck cancer	9.84e-06	5.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—head and neck cancer	9.74e-06	5.63e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—head and neck cancer	9.47e-06	5.47e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—head and neck cancer	9.43e-06	5.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK1—head and neck cancer	9.36e-06	5.41e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EGFR—head and neck cancer	9.36e-06	5.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—head and neck cancer	9.34e-06	5.39e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—head and neck cancer	9.3e-06	5.38e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK3—head and neck cancer	8.92e-06	5.15e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—head and neck cancer	8.78e-06	5.08e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—head and neck cancer	8.71e-06	5.03e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK1—head and neck cancer	8.49e-06	4.9e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EGFR—head and neck cancer	8.48e-06	4.9e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—head and neck cancer	8.45e-06	4.88e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK3—head and neck cancer	8.32e-06	4.81e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—head and neck cancer	8.15e-06	4.71e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	8.15e-06	4.71e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—head and neck cancer	8.12e-06	4.69e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK1—head and neck cancer	7.92e-06	4.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EGFR—head and neck cancer	7.92e-06	4.57e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—head and neck cancer	7.86e-06	4.54e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—head and neck cancer	7.66e-06	4.43e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—head and neck cancer	7.54e-06	4.36e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—head and neck cancer	7.51e-06	4.34e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—head and neck cancer	7.36e-06	4.26e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—head and neck cancer	7.25e-06	4.19e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—head and neck cancer	7.12e-06	4.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—head and neck cancer	6.87e-06	3.97e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—head and neck cancer	6.81e-06	3.94e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—head and neck cancer	6.65e-06	3.85e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—head and neck cancer	6.63e-06	3.83e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—head and neck cancer	6.36e-06	3.67e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—head and neck cancer	6.16e-06	3.56e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—head and neck cancer	6.02e-06	3.48e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—head and neck cancer	5.92e-06	3.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—head and neck cancer	5.75e-06	3.32e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—head and neck cancer	5.61e-06	3.24e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	5.4e-06	3.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—head and neck cancer	4.7e-06	2.72e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—head and neck cancer	4.42e-06	2.55e-05	CbGpPWpGaD
